Skip to main content
Read about

Granulomatosis with Polyangiitis: Possible Causes & Treatment Phases

An illustration of a woman with scaling around her red nose. Blood drips from her nose and also from her right ear. Her cheeks are red. She has blue hair.
Tooltip Icon.
Last updated November 5, 2024

Granulomatosis with polyangiitis quiz

Take a quiz to find out if you have granulomatosis with polyangiitis.

Granulomatosis with polyangiitis, is a disorder in which a dysregulated immune system causes inflammation of small blood vessels.

What is granulomatosis with polyangiitis?

Granulomatosis with polyangiitis, formerly known as Wegener’s granulomatosis, is a disorder in which a dysregulated immune system causes widespread inflammation of small blood vessels throughout the body. This results in slower or impaired blood flow to your nose, sinuses, throat, lungs, and kidneys.

Symptoms can be widespread and affect various parts of the body such as the eyes and ears or respiratory system, yet usually begin more generally with fever, fatigue, a loss of appetite, and weight loss. With treatment, a full recovery is possible; however, this condition can be fatal.

Treatments include immunosuppressive medications in order to control the disease in the short- and long-term.

You should visit your primary care physician soon to provide an early diagnosis. Treatment of inflammatory diseases commonly involve prescription medications such as a steroid to decrease inflammation, and a cell-damaging medicine to kill abnormal cells.

Granulomatosis with polyangiitis symptoms

Because granulomatosis with polyangiitis is a systemic disease, it can cause a variety of symptoms. Furthermore, GPA can cause recurrent episodes with different sets of symptoms each time.

Main symptoms

Most people with GPA will develop a period of main, general symptoms that may last for weeks or months before more specific symptoms develop. This may include:

Nasal symptoms

Approximately 90 percent of people with GPA will develop some nasal symptoms, including:

Ear symptoms

Many people can also develop ear symptoms, including:

Respiratory and chest symptoms

Lung and chest-related symptoms are likely with granulomatosis with polyangiitis. These can include:

Granulomatosis with polyangiitis quiz

Take a quiz to find out if you have granulomatosis with polyangiitis.

Take a diagnosis quiz

Kidney symptoms

Kidney problems usually develop later in the course of the disease after the onset of other symptoms, and will appear as:

Skin symptoms

About one-half of people with this condition will develop skin symptoms in the form of various rashes, including:

  • Purple-colored ulcers: A common type of skin rash is a purple discoloration with overlying ulcers, usually seen on the legs.
  • Itchy wheals (urticaria)
  • Red streaks
  • Hard bumps in the skin

Neurological symptoms

Some people with this condition can develop neurological symptoms, including:

  • Headache
  • Confusion
  • Numbness or weakness: This can occur in part of the face or body.

Eye symptoms

Some people with this condition can develop eye symptoms, such as:

Granulomatosis with polyangiitis causes

The specific cause of granulomatosis with polyangiitis is unclear but is thought to involve an initial inflammatory event that causes a dysregulated immune response. GPA commonly affects individuals who are elderly or white. Triggers for developing granulomatosis with polyangiitis include infection, exposure to a toxin, a reaction to certain medications, after developing a blood clot, or certain genetic variations.

Infectious causes

Infections can cause a systemic inflammatory response throughout the body and may trigger the development of granulomatosis with polyangiitis. Specifically, Staphylococcus aureus, a common skin bacteria, is believed to potentially cause GPA and the associated widespread inflammation.

Exposure to toxins

These can also include inhaled irritants, such as:

  • Silica: This is found in mining, sandblasting, and stonework.
  • Mercury
  • Lead

Medications

Taking certain medications have been reported to trigger the development of granulomatosis with polyangiitis. A few possible medications and the conditions they are used for include:

  • Hydralazine: For severely high blood pressure
  • The antibiotic minocycline: For acne
  • Propylthiouracil: For high thyroid levels
  • Allopurinol: For Gout
  • Rifampin: For tuberculosis

Developing a blood clot

Developing a blood clot can cause an inflammatory response in the body. They commonly develop in the leg and may be brought on by:

  • Being immobile for a period of time: For example, taking a long plane ride
  • Taking oral contraceptive pills (birth control pills)
  • Cancer

Genetic variations

Certain genetic variations have been associated with an increased risk of developing this condition. These include genetic variants of a group of molecules found on certain immune cells, which may be involved in the development of granulomatosis with polyangiitis.

Granulomatosis with polyangiitis treatment

Granulomatosis with polyangiitis is a serious condition that is usually treated aggressively with medications to suppress the immune system until the active disease resolves. These medications are usually given in two phases: an initial "induction" phase and a subsequent "maintenance" phase.

"Induction" phase immunosuppressive medications

Most people with active GPA will be recommended to start with a course of "induction" immunosuppressive medications.

  • Potency: These are stronger medications that will help quickly control the active inflammation.
  • Duration: These medications are usually continued for three to six months.
  • Medication types: Usually, this will consist of a steroid medication such as methylprednisolone and/or prednisone in combination with another medication such as methotrexate, rituximab, or cyclophosphamide.

"Maintenance" phase immunosuppressive medications

After a period of induction phase medications, most people with granulomatosis with polyangiitis will be switched to a course of maintenance phase immunosuppressive medications. The goal of maintenance therapy is to prevent the disease from causing symptoms again.

  • Potency: These medications are generally less potent than the medications used during the induction phase, and thus may cause less long-term side effects.
  • Duration: Maintenance therapy is usually continued for one to two years, and may be continued indefinitely in people who have had many episodes of disease.
  • Medication types: Possible medication used for maintenance include methotrexate, rituximab, azathioprine (Imuran), or mycophenolate (Cellcept).

Additional treatment options

Some people with severe symptoms of GPA may benefit from a treatment called plasma exchange therapy or surgery to repair associated nasal deformities.

  • Plasma exchange therapy: In this treatment, your blood is removed and replaced with blood products from a healthy donor. This can help quickly remove pro-inflammatory substances in the blood and control the active disease.
  • Surgery to repair nasal deformities: People who develop nasal deformities such as the "saddle-nose deformity" may benefit from a surgery to repair the nose, which can help open up the nasal passages and result in a more normal-appearing nose.

When to seek further consultation

If you develop any symptoms of granulomatosis with polyangiitis such as fever, nosebleeds, nasal ulcers, ear pain, shortness of breath, rash, or blood in the urine, you should go to your physician. Your physician can order laboratory and imaging studies to determine if you have granulomatosis with polyangiitis, and start you on the appropriate treatment.

Questions your doctor may ask to diagnose GPA

  • Have you been feeling more tired than usual, lethargic or fatigued despite sleeping a normal amount?
  • Any fever today or during the last week?
  • Have you experienced any nausea?
  • Have you lost your appetite recently?
  • Do you have trouble sleeping?

Self-diagnose with our free Buoy Assistant if you answer yes on any of these questions.

Share your story
Once your story receives approval from our editors, it will exist on Buoy as a helpful resource for others who may experience something similar.
The stories shared below are not written by Buoy employees. Buoy does not endorse any of the information in these stories. Whenever you have questions or concerns about a medical condition, you should always contact your doctor or a healthcare provider.
Dr. Rothschild has been a faculty member at Brigham and Women’s Hospital where he is an Associate Professor of Medicine at Harvard Medical School. He currently practices as a hospitalist at Newton Wellesley Hospital. In 1978, Dr. Rothschild received his MD at the Medical College of Wisconsin and trained in internal medicine followed by a fellowship in critical care medicine. He also received an MP...
Read full bio

Was this article helpful?

8 people found this helpful
Tooltip Icon.
Read this next
Slide 1 of 7

References

  1. Granulomatosis with polyangiitis. Mayo Clinic. Published August 8, 2017. Mayo Clinic Link
  2. Granulomatosis with polyangiitis (Wegener's). American College of Rheumatology. Updated May 2017. American College of Rheumatology Link
  3. Granulomatosis with polyangiitis. Genetic and Rare Diseases Information Center. GARD Link
  4. Granulomatosis with polyangiitis. National Organization of Rare Disorders. Published 2017. NORD Link
  5. Kubaisi B, Abu Samra K, Foster CS. Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations. Intractable Rare Dis Res. 2016;5(2):61-9. NCBI Link